99%+ Purity
COA Included
Sealed Vials
Cagrilintide
Amylin analog for enhanced appetite control
Amylin analog; hunger kill switch
Key Benefits
- Extended 24-hour appetite suppression support
- Enhanced satiety signaling through brain receptors
- Delayed gastric emptying for prolonged fullness
- Convenient weekly dosing schedule
- Synergistic effects with GLP-1 therapies
- Reduced meal size and snacking behavior
- Long-acting stability versus natural amylin
Stop Fighting Hunger—Turn Off the Switch
Most appetite suppressants leave you fighting cravings all day or crash your energy into the ground. Cagrilintide works with your brain's natural satiety system to simply turn off hunger for 24+ hours. It's the difference between white-knuckling through another diet and actually forgetting to eat because you're genuinely satisfied.
Amylin receptor pathway / Brainstem appetite control centers (area postrema, nucleus tractus solitarius)
About Cagrilintide
Cagrilintide is a long-acting synthetic version of amylin, the hormone your body naturally releases alongside insulin to signal fullness. Unlike the native hormone that breaks down within minutes, this engineered analog maintains potent appetite suppression for over 24 hours while slowing gastric emptying to keep you satisfied between meals.
Who It's For
This compound is designed for individuals who struggle with constant hunger and portion control during aggressive fat loss phases or long-term weight management protocols. The weekly injection schedule and synergistic effects with GLP-1 therapies make it particularly valuable for sustained appetite control without the daily dosing fatigue of traditional suppressants.
Research Background
Cagrilintide represents an innovative approach to weight management through targeting the amylin pathway, a naturally occurring satiety system that complements insulin signaling. Amylin is a hormone produced alongside insulin by pancreatic cells, but its natural form degrades rapidly in the body. Researchers developed cagrilintide as a long-acting amylin analog that maintains the hormone's appetite-suppressing effects while remaining stable for extended periods. The compound works by: 1) Binding to specialized receptors in the brain's appetite control centers, 2) Slowing stomach emptying to promote feelings of fullness, and 3) Reducing meal size and snacking behavior through enhanced satiety signaling. Current research focuses on cagrilintide's potential as both a standalone obesity treatment and in combination with other weight management medications. Scientists are particularly interested in its synergistic effects when paired with GLP-1 receptor agonists, creating a dual-hormone approach that addresses multiple pathways involved in appetite regulation. The compound's weekly injection schedule offers a significant advantage over daily medications, potentially improving patient compliance and treatment outcomes in long-term weight management programs.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 0.1 mg/wk | |
Intermediate | 0.3 mg/wk | |
Advanced | 0.6-1 mg/wk | |
Maximum | 1.2-1.8 mg/wk |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
1
3.6 mg needed ÷ 5 per vial
Total Investment
$75
$75.00 per vial
Per Dose
0.06 mL
6 units on U-100 syringe
Doses per Vial
16
5 ÷ 0.30 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
Cagrilintide
$75.00